This is a preprint.
Scheduled feeding improves behavioral outcomes and reduces inflammation in a mouse model of Fragile X syndrome
- PMID: 39345407
- PMCID: PMC11429936
- DOI: 10.1101/2024.09.16.613343
Scheduled feeding improves behavioral outcomes and reduces inflammation in a mouse model of Fragile X syndrome
Abstract
Fragile X syndrome (FXS), a leading inherited cause of intellectual disability and autism, is frequently accompanied by sleep and circadian rhythm disturbances. In this study, we comprehensively characterized these disruptions and evaluated the therapeutic potential of a circadian-based intervention in the fragile X mental retardation 1 (FMR1) knockout (KO) mouse. The Fmr1 KO mice exhibited fragmented sleep, impaired locomotor rhythmicity, and attenuated behavioral responses to light, linked to an abnormal retinal innervation and reduction of light-evoked neuronal activation in the suprachiasmatic nucleus. Behavioral testing revealed significant deficits in social memory and increased repetitive behaviors in the mutants, which correlated with sleep fragmentation. Remarkably, a scheduled feeding paradigm (6-hour feeding/18-hour fasting) significantly enhanced circadian rhythmicity, consolidated sleep, and improved social deficits and repetitive behaviors in the Fmr1 KO mice. This intervention also normalized the elevated levels of some pro-inflammatory cytokines, including IL-12 and IFN-γ, in the mutants' blood, suggesting that its benefits extend to inflammatory pathways. These findings highlight the interplay between circadian disruption, behavior, and an inflammatory response in FXS, and provide compelling evidence that time-restricted feeding may serve as a promising non-pharmacological approach for improving core symptoms in neurodevelopmental disorders.
Similar articles
-
Altered auditory feature discrimination in a rat model of Fragile X Syndrome.PLoS Biol. 2025 Jul 1;23(7):e3003248. doi: 10.1371/journal.pbio.3003248. eCollection 2025 Jul. PLoS Biol. 2025. PMID: 40591708 Free PMC article.
-
Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome.Neuropsychopharmacology. 2024 Dec;49(13):2032-2041. doi: 10.1038/s41386-024-01956-6. Epub 2024 Sep 2. Neuropsychopharmacology. 2024. PMID: 39223257
-
Altered auditory feature discrimination in a rat model of Fragile X Syndrome.bioRxiv [Preprint]. 2025 Feb 19:2025.02.18.638956. doi: 10.1101/2025.02.18.638956. bioRxiv. 2025. Update in: PLoS Biol. 2025 Jul 1;23(7):e3003248. doi: 10.1371/journal.pbio.3003248. PMID: 40027738 Free PMC article. Updated. Preprint.
-
Systematic Review: Fragile X Syndrome Across the Lifespan with a Focus on Genetics, Neurodevelopmental, Behavioral and Psychiatric Associations.Genes (Basel). 2025 Jan 25;16(2):149. doi: 10.3390/genes16020149. Genes (Basel). 2025. PMID: 40004478 Free PMC article.
-
PTS-Related Tetrahydrobiopterin Deficiency (PTPSD).2025 Jul 10. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2025 Jul 10. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 40638773 Free Books & Documents. Review.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials